Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000;1996(2):CD000167.
doi: 10.1002/14651858.CD000167.

Plasma volume expansion for suspected impaired fetal growth

A M Gülmezoglu  1 , G J Hofmeyr
Affiliations

Plasma volume expansion for suspected impaired fetal growth

A M Gülmezoglu et al. Cochrane Database Syst Rev. 2000.

Abstract

Background: Failure of the normal expansion of plasma volume in the mother is associated with impaired fetal growth and pre-eclampsia.

Objectives: The objective of this review was to assess the effects of plasma volume expansion for suspected impaired fetal growth.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register. Date of last search: December 1999.

Selection criteria: Randomized or quasi-randomized trials of plasma volume expansion compared to no plasma volume expansion in women with suspected impaired fetal growth.

Data collection and analysis: Trial quality was assessed.

Main results: No studies were included.

Reviewer's conclusions: There is not enough evidence to evaluate the use of plasma volume expansion for suspected impaired fetal growth.

PubMed Disclaimer

Conflict of interest statement

None known.

References

References to studies excluded from this review

Bsteh 1995 {published data only}
    1. Bsteh M, Tews G, John D. Hemodilution in treatment of intrauterine dystrophy [Haemodilution bei der behandlung der intrauterinen dystrophie]. Geburtshilfe und Frauenheilkunde 1995;55:83‐6. - PubMed
Heilmann 1991 {published data only}
    1. Heilmann L, Lorch E, Hojnacki B, Muntefering H, Forster H. Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension. Infusionstherapie 1991;18:236‐43. - PubMed
Heilmann 1993 {published data only}
    1. Heilmann L, Tempelhoff G‐Fv. Doppler sonographic results following hemodilution therapy. Zeitschrift fur Geburtshilfe und Perinatologie 1993;197:43‐7. - PubMed
    1. Tempelhoff G‐Fv, Heilman L. The effect of plasma volume expansion on the uteroplacental perfusion. Clinical Hemorheology 1993;13:729‐36.

Additional references

Bernstein 2000
    1. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very low birth weight infants with intrauterine growth restriction. The Vermont Oxford Network. American Journal of Obstetrics and Gynecology 2000;182:198. - PubMed
Clarke 2000
    1. Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.1 [updated June 2000]. In: Review Manager (RevMan) [Computer program]. Version 4.1. Oxford, England: The Cochrane Collaboration, 2000.
Lin 1998
    1. Lin C, Santolaya‐Forgas J. Current concepts of fetal growth restriction: Part 1. Causes, classification, and pathophysiology. Obstetrics & Gynecology 1998;92(6):1044‐55. - PubMed
Resnik 2002
    1. Resnik R. Intrauterine growth restriction. Obstetrics & Gynecology 2002;99(3):490‐6. - PubMed

Publication types

Substances

LinkOut - more resources